Sheffield University, partner of the FishForPharma network, and their collaborators in a project running parallel to FishForPharma, has published an open-source MATLAB® Package for the Analysis of Fluorescent Neutrophil and Macrophage Migration in a Zebrafish Model.
FishForPharma will have the mid-term review meeting organized on 30 October, 2013 in Nimes, France.
The agenda of the meeting will be available soon for the participants.
A partner from FishForPharma, ZF-Screens, within a consortium of 4 organizations, has won 2012 CRACK IT PreDART Challenge Competition. The aim of the project is to predict human developmental and reproductive toxicity through non-mammalian assays such as zebrafish, C. elegans and Dictyostelium.
Nine of the Marie Curie fellows of FishForPharma were present at the 6th Zebrafish Disease Models workshop in Murcia. A lot of exciting research was presented, with work from FishForPharma highlighted in a number of talks and on many posters. Congratulations to Vincenzo Torraca for winning one of the poster prizes.
Two partners from FishForPharma, Leiden University and ZF-Screens, recently published a paper presenting detailed protocols for robotic injection of zebrafish embryos benchmarked for several applications such as injection of DNA, antisense morpholinos, microbes and human cancer cells, which open up new avenues for the use of zebrafish larvae for large compounds screens in the search for new medicines.
ZF-Health is proud to announce the workshop on "Zebrafish Models in Translational Medicine" which will take place in Courcelles-sur-Yvette, France, on October 2-4, 2013. Abstract and registration deadline: 31th July 2013.
The Center for Infection and Immunity of Lille will organize an international symposium on innate immunity at the Institut Pasteur de Lille, France from October 7-9, 2013. The theme of the symposium will be focused on “Revisiting paradigms in innate immunity”, offering the unique opportunity a forum for exchanging ideas between disparate research communities. Deadline for abstract submission and early online registration is May 31, 2013.
For further information please visit the official website.
Fundamental research using zebrafish has facilitated a technical revolution in our ability to directly edit the genome. We can now make mutations in literally any gene in the zebrafish genome. Coupled with the high throughput capability in genetic and chemical genetic screens, zebrafish research has entered into a new era, which is expected to make a significant impact toward promoting the development of personalized and precision medicine. The goal of this conference is to bring together scientists from both biological and medical research fields to accelerate the translational process of zebrafish-based knowledge to clinical applications. This will include generation of more predictive “humanizing” disease models, dissection of disease mechanisms and discovery of new disease treatment methods.